Navigation Links
Beacon Research Issues TraderNotes on CERP, SEED, OSIR, GFRE, RIMM
Date:1/7/2008

DALLAS, Jan. 7 /PRNewswire/ -- Beacon Equity Research announces the availability of TraderNotes on stocks that are making news today.

Investors can view all of the daily trading notes for free by visiting: http://www.BeaconEquityResearch.com

Today's TraderNotes include: Cereplast, Inc. (OTC Bulletin Board: CERP), Origin Agritech Limited (Nasdaq: SEED), Osiris Therapeutics, Inc. (Nasdaq: OSIR), Gulf Resources (OTC Bulletin Board: GFRE), Research In Motion (Nasdaq: RIMM)

Join the investor discussion surrounding CERP at: http://www.stockhideout.com/penny-stocks-stock-picks/20495-cerp.html

Today's TraderNotes highlights Cereplast, Inc., a company that engages in the development and commercialization of bio-based resins in the United States, Europe, and Asia.

Beacon Research's TraderNotes are brief analyses on the active stocks each day that are affecting the markets. These include breaking news, insider activity, recent 52-week highs/lows, technical breakouts, and other market driving information. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.

We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http://www.BeaconEquityResearch.com

Beacon Equity Research is one of the industry's largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquityResearch.com CRD# 2954278

Beacon Equity Research Disclosure

The companies that are discussed have not always approved the statements made in this opinion. These reports are for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell any securities mentioned. We are not a licensed or registered broker dealer, investment advisor, analyst or underwriter. Please consult a registered broker before purchasing or selling any securities viewed or mentioned here. Beacon Equity Research has been compensated fifteen thousand dollars directly from the company for enrollment of CERP in this research program.

Beacon Equity Research

Jeff Bishop, (469) 252-3505

press@beaconequityresearch.com

Reuel Scott Sanchez of Beacon Equity Research is a member of the National Association of Securities Dealers, CRD number 2954278.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. JEFF BISHOP http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=70781


'/>"/>
SOURCE Beacon Equity Research
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. OneBeacon Appoints Southern Marine & Aviation Inc.
2. OneBeacon Professional Partners to Offer Podiatrist Medical Malpractice Product
3. Research Gets Closer to Origin of Parkinsons Disease
4. amfAR announces inaugural Mathilde Krim Fellowship Awards for AIDS research
5. Researchers use neuroimaging to study ESP
6. UGA researchers receive $9 million in grants to study barriers to effective addiction treatment
7. Jan Marini Skin Research Gives Familiar Logo a Facelift
8. Researchers seek to make cavity-causing bacteria self-destruct
9. Research suggests new treatment suitable for all patients
10. 2007: A Watershed Year for Lupus Research and Education
11. FASgen Announces New Research Discoveries in Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology: